文献速递其他结缔组织病

抗MDA5抗体阳性皮肌炎中的自发性纵隔气肿:患病率、危险因素与预后

Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.
PubMed 文献 · Semin Arthritis Rheum · 2024-01-03

回顾性纳入1352例特发性炎症性肌病(IIM)患者,其中抗MDA5抗体阳性皮肌炎(抗MDA5+ DM)384例,分析其自发性纵隔气肿(SPM)的临床特征。抗MDA5+ DM中SPM发生率为9.4%(36/384),巨细胞病毒(CMV)感染和真菌感染是SPM发生的独立危险因素;SPM的发生未加重抗MDA5+ DM患者的生存,而加强免疫抑制治疗(IST)与SPM患者死亡风险升高相关。

要点

  • 抗MDA5+ DM患者SPM发生率为9.4%(36/384),显著高于非抗MDA5+ DM及其他IIM亚型(P均<0.001)。
  • CMV感染与真菌感染是抗MDA5+ DM发生SPM的独立危险因素。
  • SPM组与非SPM组短期及长期生存无显著差异(P=0.236)。

核心结论

  • 近十分之一的抗MDA5+ DM患者发生SPM。
  • CMV感染与真菌感染均为SPM发生的危险因素。
  • SPM的发生不恶化抗MDA5+ DM患者的预后,而加强IST损害SPM的预后。

研究设计与样本

  • 回顾性纳入1352例特发性炎症性肌病(IIM)患者,其中抗MDA5+ DM患者384例,分析抗MDA5+ DM相关SPM的临床特征。

主要发现

  • 抗MDA5+ DM患者中9.4%(36/384)合并SPM,显著高于非抗MDA5+ DM及其他IIM亚型(P均<0.001)。
  • SPM发生于抗MDA5+ DM起病后中位5.5(3.0,12.0)个月。
  • 合并SPM的抗MDA5+ DM患者发热、呼吸困难及肺部感染(包括病毒感染和真菌感染)的发生频率显著高于无SPM者(P均<0.05)。
  • CMV感染与真菌感染是抗MDA5+ DM发生SPM的独立危险因素。
  • 抗MDA5+ DM队列中SPM与非SPM患者短期及长期生存相当(P=0.236)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To depict the clinical panorama of spontaneous pneumomediastinum (SPM) in anti-MDA5 antibody-positive dermatomyositis (anti-MDA5+ DM). METHODS: A total of 1352 patients with idiopathic inflammatory myopathy (IIM), including 384 anti-MDA5+ DM patients were retrospectively enrolled. The clinical profiles of anti-MDA5+ DM-associated SPM were analyzed. RESULTS: We identified that 9.4 % (36/384) of anti-MDA5+ DM patients were complicated with SPM, which was significantly higher than that of non-anti-MDA5+ DM and other IIM subtypes (P all <0.001). SPM developed at a median of 5.5 (3.0, 12.0) months after anti-MDA5+ DM onset. Anti-MDA5+ DM patients complicated with SPM showed a significantly higher frequency of fever, dyspnea, and pulmonary infection including viral and fungal infections compared to those without SPM (P all < 0.05). Cytomegalovirus (CMV) and fungal infections were identified to be independent risk factors for SPM development in the anti-MDA5+ DM. SPM and non-SPM patients in our anti-MDA5+ DM cohort showed comparable short-term and long-term survival (P = 0.236). Furthermore, in the SPM group, we found that the non-survivors had a lower peripheral lymphocyte count, higher LDH level, and higher frequency of intensification of immunosuppressive treatment (IST) than survivors. The elevated LDH level and intensification of IST were independent risk factors for increased mortality in anti-MDA5+ DM-associated SPM patients. CONCLUSIONS: Nearly one-tenth of patients with anti-MDA5+ DM develop SPM. Both CMV and fungal infections are risk factors for SPM occurrence. The development of SPM does not worsen the prognosis of anti-MDA5+ DM patients, and the intensification of IST does harm to the SPM prognosis.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Jin Q, Lin S, Chen X, et al. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis. Semin Arthritis Rheum. 2024. PMID: 38185078. doi:10.1016/j.semarthrit.2023.152352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。